Table 1.
The characteristic of 107 participants (54 in metformin group and 53 in repaglinide group) with type 2 diabetes, diagnosed according to World Health Organization criteria.
| Parameters | Group metformin | Group repaglinide | ||||
|---|---|---|---|---|---|---|
| Men | Women | Both | Men | Women | Both | |
| Gender | 30 | 24 | 54 | 31 | 22 | 53 |
| Mean age | 55.4 ± 2.2 | 57.5 ± 2.4 | 56.4 ± 1.6 | 56.9 ± 1.7 | 59.1 ± 2.1 | 57.8 ± 1.3 |
| BMI | 26.18 ± 0.57 | 26.11 ± 0.78 | 26.15 ± 0.46 | 24.80 ± 0.43 | 23.96 ± 0.50 | 24.45 ± 0.33 |
| HbAlc | 7.11 ± 0.18 | 6.76 ± 0.13 | 6.95 ± 0.12 | 7.38 ± 0.16 | 7.48 ± 0.22 | 7.42 ± 0.13 |
| FPG | 7.28 ± 0.23 | 7.04 ± 0.17 | 7.17 ± 0.15 | 7.72 ± 0.20 | 7.72 ± 0.31 | 7.72 ± 0.17 |
| FPI | 11.36 ± 1.08 | 12.69 ± 1.81 | 11.95 ± 1.00 | 8.17 ± 0.75 | 8.49 ± 0.73 | 8.30 ± 0.53 |
| TC | 5.38 ± 0.17 | 5.25 ± 0.18 | 5.32 ± 0.12 | 4.98 ± 0.16 | 5.75 ± 0.23 | 5.30 ± 0.14 |
| TG | 2.11 ± 0.20 | 1.77 ± 0.15 | 1.96 ± 0.13 | 1.97 ± 0.20 | 2.14 ± 0.26 | 2.04 ± 0.16 |
| HDL | 1.26 ± 0.10 | 1.28 ± 0.06 | 1.27 ± 0.06 | 1.23 ± 0.05 | 1.51 ± 0.15 | 1.35 ± 0.07 |
| LDL | 3.34 ± 0.13 | 3.28 ± 0.14 | 3.32 ± 0.09 | 3.18 ± 0.16 | 3.48 ± 0.24 | 3.30 ± 0.13 |
Data are shown by means and standard errors. It was only different in TC between men and women of repaglinide group (P < 0.05).